Matches in Wikidata for { <http://www.wikidata.org/entity/Q92036493> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- Q92036493 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q92036493 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92036493 description "scientific article published on 15 April 2020" @default.
- Q92036493 description "wetenschappelijk artikel" @default.
- Q92036493 description "наукова стаття, опублікована 15 квітня 2020" @default.
- Q92036493 name "National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy" @default.
- Q92036493 name "National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy" @default.
- Q92036493 type Item @default.
- Q92036493 label "National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy" @default.
- Q92036493 label "National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy" @default.
- Q92036493 prefLabel "National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy" @default.
- Q92036493 prefLabel "National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy" @default.
- Q92036493 P1433 Q92036493-AD25604F-5865-4A8C-A4AD-DF7272B232D4 @default.
- Q92036493 P1476 Q92036493-BFAC61AE-6B84-4864-92A4-35056CB54F79 @default.
- Q92036493 P2093 Q92036493-243B4760-A9AC-4F3D-B4C7-4124D2BC8D59 @default.
- Q92036493 P2093 Q92036493-4B77933B-CF28-42E9-9EFC-04A3EE42BEFA @default.
- Q92036493 P2093 Q92036493-6F21630F-CA7B-4D73-9195-63991BEE8282 @default.
- Q92036493 P2093 Q92036493-D15B7483-3AF8-4FA2-B230-CC7858104775 @default.
- Q92036493 P2860 Q92036493-0D803C0D-F9EB-409B-A248-F4B2F9ED0B39 @default.
- Q92036493 P2860 Q92036493-13EB60D4-26F6-4BD3-85D6-97D414CB4C14 @default.
- Q92036493 P2860 Q92036493-326E2E65-8AF3-4492-8689-D0615CB1E98B @default.
- Q92036493 P2860 Q92036493-4F8C7477-C590-46C1-B7EA-B8AE2A7462C5 @default.
- Q92036493 P2860 Q92036493-515D2C0F-1202-4C0A-9990-C8D165C45F12 @default.
- Q92036493 P2860 Q92036493-60A82A28-F1FA-4470-B580-FA1FFB7B7192 @default.
- Q92036493 P2860 Q92036493-6CFC963A-B1A4-4E8B-86C4-33C645DBDE33 @default.
- Q92036493 P2860 Q92036493-74927394-50AA-47FD-9920-C4853DE82932 @default.
- Q92036493 P2860 Q92036493-8E2EC17C-88A5-47E8-855C-7731E16C7043 @default.
- Q92036493 P2860 Q92036493-A23CB2B6-8AAD-4F36-BEF8-1CF52DCC2FCC @default.
- Q92036493 P2860 Q92036493-B7F707EA-62FD-43F1-BC98-70D4BC774DBD @default.
- Q92036493 P2860 Q92036493-C7899336-064E-4A38-88C5-CC8B8DAC1DA3 @default.
- Q92036493 P2860 Q92036493-CAF1C22D-E75D-4245-8B5F-297F1502F5D3 @default.
- Q92036493 P2860 Q92036493-DED6C1B1-1A32-4B4C-94E4-BB11FDD6C2AE @default.
- Q92036493 P2860 Q92036493-E217D832-4E1F-4CA3-B86E-B7CC212F9919 @default.
- Q92036493 P2860 Q92036493-E2BAFBA3-5E4E-4D27-A753-46CEA15832B7 @default.
- Q92036493 P2860 Q92036493-E99A7F63-242F-4D6F-AB8B-88346DFF3BA0 @default.
- Q92036493 P2860 Q92036493-EAFE6757-E2D5-40B4-8FFD-A1FC5DA88361 @default.
- Q92036493 P2860 Q92036493-ECE52CE5-A1E4-42F9-9EC5-221560145060 @default.
- Q92036493 P2860 Q92036493-F9A59AE0-39E5-42DC-858B-DB92EFAA4503 @default.
- Q92036493 P31 Q92036493-FF8BFEB2-600A-42A1-A600-63B6DD5C4C9F @default.
- Q92036493 P356 Q92036493-1171632F-D3FA-4DCE-8D0C-B9B666D15570 @default.
- Q92036493 P50 Q92036493-A3CBA3DF-04FB-4374-B889-6F518DE1FB80 @default.
- Q92036493 P577 Q92036493-80E44033-4AB4-4C1A-B03F-562F8BA855E8 @default.
- Q92036493 P698 Q92036493-528FBDF2-1CC2-46E2-81C0-42510B52C433 @default.
- Q92036493 P356 J.UROLONC.2020.03.014 @default.
- Q92036493 P698 32305267 @default.
- Q92036493 P1433 Q2113446 @default.
- Q92036493 P1476 "National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy" @default.
- Q92036493 P2093 "Logan B Galansky" @default.
- Q92036493 P2093 "Ryan P Werntz" @default.
- Q92036493 P2093 "Scott E Eggener" @default.
- Q92036493 P2093 "Vignesh T Packiam" @default.
- Q92036493 P2860 Q33790550 @default.
- Q92036493 P2860 Q35721076 @default.
- Q92036493 P2860 Q38833535 @default.
- Q92036493 P2860 Q39534435 @default.
- Q92036493 P2860 Q39882587 @default.
- Q92036493 P2860 Q43535760 @default.
- Q92036493 P2860 Q44748837 @default.
- Q92036493 P2860 Q47239998 @default.
- Q92036493 P2860 Q52607686 @default.
- Q92036493 P2860 Q52688188 @default.
- Q92036493 P2860 Q59571742 @default.
- Q92036493 P2860 Q59571872 @default.
- Q92036493 P2860 Q59571896 @default.
- Q92036493 P2860 Q59571927 @default.
- Q92036493 P2860 Q71561557 @default.
- Q92036493 P2860 Q73166866 @default.
- Q92036493 P2860 Q74551354 @default.
- Q92036493 P2860 Q79907975 @default.
- Q92036493 P2860 Q91791257 @default.
- Q92036493 P2860 Q92388576 @default.
- Q92036493 P31 Q13442814 @default.
- Q92036493 P356 "10.1016/J.UROLONC.2020.03.014" @default.
- Q92036493 P50 Q61784916 @default.
- Q92036493 P577 "2020-04-15T00:00:00Z" @default.
- Q92036493 P698 "32305267" @default.